Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome

Purpose. Injection of anti-VEGF antibody into the vitreous body is a well-established treatment for ischemic central retinal vein occlusion (CRVO) associated macular edema. Various treatment regimens regarding the timing, number, and frequency of injections have been proposed. Methods. We reviewed t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pikkel, Joseph, Chassid, Otzem, Busool, Yumna, Srour, Ward, Sharabi-Nov, Adi, Beiran, Itzchak
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3893752/
https://ncbi.nlm.nih.gov/pubmed/24490054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/974670
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak